In order to increase profitability over a sustained period, Clariant implements measures designed to improve the Group’s performance. The aim of these efforts is to increase the Group’s operating result and to reduce net working capital. The changes made to the processes and structures result in a reduction of headcount across the Group.

Restructuring. In 2019, Clariant recorded expenses for restructuring in the amount of CHF 14 million (2018: CHF 14 million). This concerned restructuring measures mainly in France and Germany.

Impairment. No impairment losses were recorded in 2019 and 2018.

Transaction-related costs comprise expenses incurred in connection with acquisition or disposal projects and also costs incurred in connection with the implementation of internal reorganizational measures.

The total amount pertaining to continuing operations of CHF 50 million of Restructuring, impairment and transaction-related costs (2018: CHF 78 million) is reported in the income statement from continuing operations as follows: CHF 9 million in Cost of goods sold (2018: CHF 10 million), CHF 43 million in Selling, general and administrative costs (2018: CHF 67 million), CHF 2 million income in Research & Development costs (2018: CHF 1 million expenses).